sanger capillary sequencing Search Results


90
LGC Genomics GmbH standard capillary sanger sequencing
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Standard Capillary Sanger Sequencing, supplied by LGC Genomics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pmc05144678-98-5-13?v=LGC+Genomics+GmbH
Average 90 stars, based on 1 article reviews
standard capillary sanger sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
First BASE Laboratories sequencing analysis using sanger dna sequencing with capillary electrophoresis
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Sequencing Analysis Using Sanger Dna Sequencing With Capillary Electrophoresis, supplied by First BASE Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pm38938032-74-22-14?v=First+BASE+Laboratories
Average 90 stars, based on 1 article reviews
sequencing analysis using sanger dna sequencing with capillary electrophoresis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
DuPont de Nemours sanger capillary sequencers dupont sequencing
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Sanger Capillary Sequencers Dupont Sequencing, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pm25108866-75-9-12?v=DuPont+de+Nemours
Average 90 stars, based on 1 article reviews
sanger capillary sequencers dupont sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
SeqOmics Biotechnology Ltd sanger capillary sequencing
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Sanger Capillary Sequencing, supplied by SeqOmics Biotechnology Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pmc11162026-101-14-21?v=SeqOmics+Biotechnology+Ltd
Average 90 stars, based on 1 article reviews
sanger capillary sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
LGC Genomics GmbH capillary sanger sequencing
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Capillary Sanger Sequencing, supplied by LGC Genomics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pmc04343121-190-4-13?v=LGC+Genomics+GmbH
Average 90 stars, based on 1 article reviews
capillary sanger sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GeneDx Inc capillary sanger sequencing
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Capillary Sanger Sequencing, supplied by GeneDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/pm22264778-109-11-25?v=GeneDx+Inc
Average 90 stars, based on 1 article reviews
capillary sanger sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GATC Biotech sanger dideoxy sequencing on capillary sequencers
(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger <t>sequencing</t> (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.
Sanger Dideoxy Sequencing On Capillary Sequencers, supplied by GATC Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sanger+capillary+sequencing/10__1002_slash_tax__12035-77-10-5?v=GATC+Biotech
Average 90 stars, based on 1 article reviews
sanger dideoxy sequencing on capillary sequencers - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger sequencing (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.

Journal: DNA Research: An International Journal for Rapid Publication of Reports on Genes and Genomes

Article Title: Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications

doi: 10.1093/dnares/dsw038

Figure Lengend Snippet: (A) Inserts used in the analysis of different lesions. The inserts were designed with uracils (U) on one or both strands, different mismatches placed randomly in the sequence, an 8-oxoG with a deletion (-) at the opposite position, or methylated cytosines (5-me) within a CpG context. The underlined dinucleotides represent the sequence difference between the plasmid (HSI_vector) and the vector-insert construct (HSI_insert). (B) Strategy used for the analysis of amplifiable DNA lesions. Three different DNA sources were amplified with smPCR: the vector-insert construct (HSI_insert 1-6), a plasmid DNA (HSI_vector), and human genomic DNA, and then analyzed with Sanger sequencing (or in some cases with genotyping). Duplex sequencing was performed directly on the inserts 2, 3, 5, and 6.

Article Snippet: Sequencing was performed by standard capillary Sanger sequencing in a 96-well format (by LGC Genomics GmbH), as described previously.

Techniques: Sequencing, Methylation, Plasmid Preparation, Construct, Amplification

Types of nucleotide substitutions in the amplification of the 8-oxoG lesion. The percentage of different substitutions observed at the 8-oxoG site is shown for SSCSs in duplex sequencing (57,092 total analyzed reads) and Sanger sequencing reads of smPCR products (25 total analyzed smPCR reactions), detailed numbers are shown in Supplementary Table S3 . GC and GT in smPCR represent different nucleotides opposite the 8-oxoG in the heterogeneous peak of the sequencing chromatogram. In duplex sequencing, these are represented as an N , where N represents the presence of more than one nucleotide in the duplex sequencing reads, with the predominant nucleotide being found in less than 70% of the reads. Error bars represent Poisson 95% CIs.

Journal: DNA Research: An International Journal for Rapid Publication of Reports on Genes and Genomes

Article Title: Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications

doi: 10.1093/dnares/dsw038

Figure Lengend Snippet: Types of nucleotide substitutions in the amplification of the 8-oxoG lesion. The percentage of different substitutions observed at the 8-oxoG site is shown for SSCSs in duplex sequencing (57,092 total analyzed reads) and Sanger sequencing reads of smPCR products (25 total analyzed smPCR reactions), detailed numbers are shown in Supplementary Table S3 . GC and GT in smPCR represent different nucleotides opposite the 8-oxoG in the heterogeneous peak of the sequencing chromatogram. In duplex sequencing, these are represented as an N , where N represents the presence of more than one nucleotide in the duplex sequencing reads, with the predominant nucleotide being found in less than 70% of the reads. Error bars represent Poisson 95% CIs.

Article Snippet: Sequencing was performed by standard capillary Sanger sequencing in a 96-well format (by LGC Genomics GmbH), as described previously.

Techniques: Amplification, Sequencing

Strand-amplification bias of insert_3 with and without USER treatment measured by duplex sequencing. Based on a total of 34,072 reads for insert_3 (one uracil in the forward strand), 6,096 SSCSs were formed with the strand containing uracil (forward strand) and 27,976 for the strand without the uracil (reverse strand). After USER treatment, a total of 34,636 reads were obtained, of which, 138 and 34,498 formed SSCSs for the forward and reverse strand, respectively. Detailed numbers can be found in Supplementary Table S6 . The proportion of amplifiable forward strands could be significantly decreased with USER treatment ( P < 2.2 × 10 − 16 , Fisher’s exact test). Error bars represent Poisson 95% CIs.

Journal: DNA Research: An International Journal for Rapid Publication of Reports on Genes and Genomes

Article Title: Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications

doi: 10.1093/dnares/dsw038

Figure Lengend Snippet: Strand-amplification bias of insert_3 with and without USER treatment measured by duplex sequencing. Based on a total of 34,072 reads for insert_3 (one uracil in the forward strand), 6,096 SSCSs were formed with the strand containing uracil (forward strand) and 27,976 for the strand without the uracil (reverse strand). After USER treatment, a total of 34,636 reads were obtained, of which, 138 and 34,498 formed SSCSs for the forward and reverse strand, respectively. Detailed numbers can be found in Supplementary Table S6 . The proportion of amplifiable forward strands could be significantly decreased with USER treatment ( P < 2.2 × 10 − 16 , Fisher’s exact test). Error bars represent Poisson 95% CIs.

Article Snippet: Sequencing was performed by standard capillary Sanger sequencing in a 96-well format (by LGC Genomics GmbH), as described previously.

Techniques: Amplification, Sequencing

Measured substitutions in duplex sequencing of insert 6 in differently treated samples. Duplex sequencing of insert 6 was performed without any treatment (control), after repeated freeze-thaw cycles (frozen), and after heating to 65 °C for 3 h (heated). (A) Comparison of substitution frequencies at 5-methylcytosines (C-met) versus unmethylated C; detailed numbers are shown in Supplementary Table S9 . (B) Transition and transversion frequencies in SSCS reads of differently treated/stored samples (repeatedly frozen/thawed or heated to 65 °C). Due to the relatively high number of indels introduced during DNA Ultramer synthesis, this type of mutation was not considered in the analysis. Significant differences were only observed between the control and heated sample for G->T and C->G transversions. An analysis of the nucleotide context of the observed G->T mutations is shown in Supplementary Fig. S5 . Error bars represent Poisson 95% CIs. Significance values were estimated using a Fisher’s exact test.

Journal: DNA Research: An International Journal for Rapid Publication of Reports on Genes and Genomes

Article Title: Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications

doi: 10.1093/dnares/dsw038

Figure Lengend Snippet: Measured substitutions in duplex sequencing of insert 6 in differently treated samples. Duplex sequencing of insert 6 was performed without any treatment (control), after repeated freeze-thaw cycles (frozen), and after heating to 65 °C for 3 h (heated). (A) Comparison of substitution frequencies at 5-methylcytosines (C-met) versus unmethylated C; detailed numbers are shown in Supplementary Table S9 . (B) Transition and transversion frequencies in SSCS reads of differently treated/stored samples (repeatedly frozen/thawed or heated to 65 °C). Due to the relatively high number of indels introduced during DNA Ultramer synthesis, this type of mutation was not considered in the analysis. Significant differences were only observed between the control and heated sample for G->T and C->G transversions. An analysis of the nucleotide context of the observed G->T mutations is shown in Supplementary Fig. S5 . Error bars represent Poisson 95% CIs. Significance values were estimated using a Fisher’s exact test.

Article Snippet: Sequencing was performed by standard capillary Sanger sequencing in a 96-well format (by LGC Genomics GmbH), as described previously.

Techniques: Sequencing, Control, Comparison, Mutagenesis